Inhaled human insulin

被引：8

作者：

Owens, DR ^{[1
]}

Grimley, J

Kirkpatrick, P

机构：

[1] Cardiff Univ, Llandough Hosp, Diabet Res Unit, Cardiff CF64 2XX, S Glam, Wales

[2] IMS Hlth, London NW1 6JB, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2006年 / 5卷 / 05期

关键词：

D O I：

10.1038/nrd2052

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

In January 2006, human insulin inhalation powder (Exubera; Pfizer) was approved by the US FDA and the EMEA for the treatment of adult patients with diabetes mellitus. It is the first non-injectable insulin to be approved.

引用

页码：371 / 372

页数：2

共 13 条

[1] Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study [J].

Adler, AI ;

Stratton, IM ;

Neil, HAW ;

Yudkin, JS ;

Matthews, DR ;

Cull, CA ;

Wright, AD ;

Turner, RC ;

Holman, RR .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7258) :412-419

[2] The burden of treatment failure in type 2 diabetes [J].

Brown, JB ;

Nichols, GA ;

Perry, A .

DIABETES CARE, 2004, 27 (07) :1535-1540

[3] Efficacy of inhaled insulin in patients with type 2 diabetes not controlled with diet and exercise - A 12-week, randomized, comparative trial [J].

DeFronzo, RA ;

Bergenstal, RM ;

Cefalu, WT ;

Pullman, J ;

Lerman, S ;

Bode, BW ;

Phillips, LS .

DIABETES CARE, 2005, 28 (08) :1922-1928

[4]

Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563

[5] Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes - Results of a 6-month, randomized, comparative trial [J].

Hollander, PA ;

Blonde, L ;

Rowe, R ;

Mehta, AE ;

Milburn, JL ;

Hershon, KS ;

Chiasson, JL ;

Levin, SR .

DIABETES CARE, 2004, 27 (10) :2356-2362

[6]

*IMS HLTH, 2005, IMS MIDAS QUANT MAT

[7]

Leahy Jack L., 2002, INSULIN THERAPY

[8] New horizons - Alternative routes for insulin therapy [J].

Owens, DR .

NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (07) :529-540

[9] Resistance to insulin therapy among patients and providers - Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study [J].

Peyrot, M ;

Rubin, RR ;

Lauritzen, T ;

Skovlund, SE ;

Snoek, FJ ;

Matthews, DR ;

Landgraf, RD ;

Kleinebreil, L .

DIABETES CARE, 2005, 28 (11) :2673-2679

[10] Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes -: Results of a 6-month, randomized, comparative trial [J].

Quattrin, T ;

Bélanger, A ;

Bohannon, NJV ;

Schwartz, SL .

DIABETES CARE, 2004, 27 (11) :2622-2627

← 1 2 →